Enliven Therapeutics (ELVN) Financials: Revenue & Earnings

ELVN price $44.48 +0.79 +1.80%

Ticker
ELVN
Price
$44.48
Change
+0.79 +1.80%
Market cap ?
$3.26B
P/E ?
-25.32
Dividend yield ?
0.00%
Beta ?
0.24
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
58
Quality
47
Growth
100

Stocklytics score rationale: value 58, quality 47, growth 100.

Financials

201720182019202020212022202320242025
000000000

Enliven Therapeutics, Inc. is a biopharmaceutical enterprise, currently in the clinical development phase, dedicated to discovering and advancing small molecule therapeutic agents aimed at combating cancer. Its pipeline includes ELVN-001, a small molecule kinase inhibitor currently in a Phase 1 clinical trial for adult patients with chronic myeloid leukemia. Another key candidate, ELVN-002, also a small molecule…

Fair value

ELVN fair value Not meaningful. Price $44.48.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ELVN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.45——
2026-08-05-0.49-0.39——
2026-05-07-0.38-0.44——
2026-03-03-0.48-0.42—12.50K
2025-11-12-0.32-0.43—8.33K
2025-08-13-0.49-0.53——
2025-05-14-0.57-0.51——
2025-03-13-0.46-0.53——
2024-11-13-0.48-0.52——
2024-08-13-0.41-0.58——
2024-05-14-0.54-0.58——
2024-03-14-0.47-0.56440.00K—
2023-11-09-0.51-0.49——
2023-08-10-0.41-0.40——
2023-05-11-0.80-0.67——
2023-02-101.23-0.79——
2022-10-25-0.72-1.00——
2022-08-03-1.76-2.05——
2022-05-06-2.24-2.31——
2022-03-15-2.12-3.00——
2021-11-09-2.20-3.38——
2021-08-06-2.96-3.20——
2021-05-11-2.32-3.34——
2021-03-05-2.24-3.35——
2020-11-05-2.88-3.21——
2020-08-14-2.36-2.25——
2020-05-07-17.24-2.94——
2020-03-11-1.53———
2019-12-31-1.68———
2019-06-30-1.25———
2019-03-31-0.97———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-19Hohl BenjaminSell6.02K$14.8589.37K
2026-10-19Hohl BenjaminBuy6.02K$14.8589.37K
2026-10-19Hohl BenjaminSell6.02K$38.48231.55K
2026-10-19Collins Helen LouiseSell5.00K$2.4812.40K
2026-10-19Collins Helen LouiseBuy5.00K$2.4812.40K
2026-10-19Collins Helen LouiseSell5.00K$38.47192.34K
2026-10-14BALL KRISTINE MBuy23.39K$39.28918.92K
2026-10-14BALL KRISTINE MOther0——
2026-10-01Garland J. ScottSell13.00K$15.47201.11K
2026-10-01Garland J. ScottBuy13.00K$15.47201.11K
2026-10-01Garland J. ScottSell13.00K$46.67606.72K
2026-09-17Hohl BenjaminSell3.98K$14.8559.13K
2026-09-17Hohl BenjaminBuy3.98K$14.8559.13K
2026-09-17Hohl BenjaminSell3.54K$50.03176.85K
2026-09-17Hohl BenjaminSell2.19K$50.72111.27K
2026-09-17Hohl BenjaminSell289$51.4914.88K
2026-09-17Collins Helen LouiseSell5.00K$2.4812.40K
2026-09-17Collins Helen LouiseBuy5.00K$2.4812.40K
2026-09-17Collins Helen LouiseSell2.92K$50.03145.89K
2026-09-17Collins Helen LouiseSell1.84K$50.7193.51K
2026-09-17Collins Helen LouiseSell240$51.4812.36K
2026-08-17Hohl BenjaminSell4.63K$58.35270.17K
2026-08-17Hohl BenjaminSell1.39K$59.3582.38K
2026-08-17Collins Helen LouiseSell5.00K$2.4812.40K
2026-08-17Collins Helen LouiseBuy5.00K$2.4812.40K
2026-08-17Collins Helen LouiseSell3.90K$58.37227.65K
2026-08-17Collins Helen LouiseSell1.10K$59.3565.28K
2026-08-04Derynck Mika KBuy20.49K$22.47460.43K
2026-08-04Derynck Mika KBuy23.36K$14.85346.96K
2026-08-04Derynck Mika KBuy27.57K$25.28696.89K
2026-08-04Derynck Mika KBuy87.37K$2.48216.69K
2026-08-04Derynck Mika KSell158.79K$60.219.56M
2026-08-04Derynck Mika KSell87.37K$2.48216.69K
2026-08-04Derynck Mika KSell27.57K$25.28696.89K
2026-08-04Derynck Mika KSell23.36K$14.85346.96K
2026-08-04Derynck Mika KSell20.49K$22.47460.43K
2026-07-17Hohl BenjaminSell1.07K$2.482.66K
2026-07-17Hohl BenjaminBuy1.07K$2.482.66K
2026-07-17Hohl BenjaminSell324$49.9716.19K
2026-07-17Hohl BenjaminSell369$51.4819.00K
2026-07-17Hohl BenjaminSell2.56K$52.32134.14K
2026-07-17Hohl BenjaminSell2.64K$53.38140.82K
2026-07-17Hohl BenjaminSell123$53.876.63K
2026-07-17Collins Helen LouiseSell5.00K$2.4812.40K
2026-07-17Collins Helen LouiseBuy5.00K$2.4812.40K
2026-07-17Collins Helen LouiseSell231$50.0511.56K
2026-07-17Collins Helen LouiseSell459$51.5523.66K
2026-07-17Collins Helen LouiseSell2.06K$52.39108.08K
2026-07-17Collins Helen LouiseSell2.18K$53.42116.67K
2026-07-17Collins Helen LouiseSell63$53.923.40K
2026-07-06Kunkel Lori AnneSell4.11K$49.98205.48K
2026-07-06Kunkel Lori AnneSell5.89K$50.84299.42K
2026-06-22ORBIMED ADVISORS LLCSell787.02K$45.3835.72M
2026-06-22ORBIMED ADVISORS LLCSell46.78K$45.002.10M
2026-06-22ORBIMED ADVISORS LLCSell24.85K$45.381.13M
2026-06-22ORBIMED ADVISORS LLCSell1.48K$45.0066.47K
2026-06-17Hohl BenjaminSell6.02K$2.4814.92K
2026-06-17Hohl BenjaminBuy6.02K$2.4814.92K
2026-06-17Hohl BenjaminSell1.38K$42.7859.00K
2026-06-17Hohl BenjaminSell3.40K$43.86149.18K
2026-06-17Hohl BenjaminSell1.24K$44.7555.40K
2026-06-17Collins Helen LouiseSell5.00K$2.4812.40K
2026-06-17Collins Helen LouiseBuy5.00K$2.4812.40K
2026-06-17Collins Helen LouiseSell1.27K$42.8354.30K
2026-06-17Collins Helen LouiseSell2.60K$43.87114.02K
2026-06-17Collins Helen LouiseSell1.13K$44.7450.69K
2026-06-15ORBIMED ADVISORS LLCSell272.32K$45.0212.26M
2026-06-15ORBIMED ADVISORS LLCSell9.09K$45.02409.05K
2026-06-05Kunkel Lori AnneSell7.78K$34.28266.66K
2026-06-05Kunkel Lori AnneSell1.87K$35.3666.01K
2026-06-05Kunkel Lori AnneSell354$35.8212.68K
2026-05-18Collins Helen LouiseSell5.00K$2.4812.40K
2026-05-18Collins Helen LouiseBuy5.00K$2.4812.40K
2026-05-18Collins Helen LouiseSell3.48K$39.53137.38K
2026-05-18Collins Helen LouiseSell1.30K$40.2552.40K
2026-05-18Collins Helen LouiseSell223$41.219.19K
2026-04-17Collins Helen LouiseSell5.00K$2.4812.40K
2026-04-17Collins Helen LouiseBuy5.00K$2.4812.40K
2026-04-17Collins Helen LouiseSell140$45.816.41K
2026-04-17Collins Helen LouiseSell2.42K$47.39114.64K
2026-04-17Collins Helen LouiseSell2.44K$48.06117.30K
2026-03-25Collins Helen LouiseSell40.00K$2.4899.20K
2026-03-25Collins Helen LouiseBuy40.00K$2.4899.20K
2026-03-25Collins Helen LouiseSell40.00K$35.101.40M
2026-03-17Collins Helen LouiseSell5.00K$2.4812.40K
2026-03-17Collins Helen LouiseBuy5.00K$2.4812.40K
2026-03-17Collins Helen LouiseSell5.00K$27.76138.80K
2026-03-10Collins Helen LouiseSell10.13K$2.4825.12K
2026-03-10Collins Helen LouiseBuy10.13K$2.4825.12K
2026-03-10Collins Helen LouiseSell10.13K$30.19305.83K
2026-03-09Collins Helen LouiseSell29.87K$2.4874.08K
2026-03-09Collins Helen LouiseBuy29.87K$2.4874.08K
2026-03-09Collins Helen LouiseSell29.87K$30.02896.81K
2026-03-06Hohl BenjaminSell10.00K$29.58295.84K
2026-02-17Heyman Richard A.Sell1.23K$26.1832.20K
2026-02-17Collins Helen LouiseSell45.00K$2.48111.60K
2026-02-17Collins Helen LouiseBuy45.00K$2.48111.60K
2026-02-17Collins Helen LouiseSell45.00K$26.171.18M
2026-02-12Kunkel Lori AnneBuy17.13K$27.16465.14K
2026-02-12Heyman Richard A.Buy19.23K$27.16522.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 222, holders +42 vs prior quarter. Ownership 121.88%.

HolderSharesChangeChange %Value
FMR LLC10.03M3.20M+46.80%508.77M
ORBIMED ADVISORS LLC6.78M-1.18M-14.86%343.91M
POLAR CAPITAL HOLDINGS PLC6.43M1.36M+26.94%326.35M
BLACKROCK, INC.4.36M675.00K+18.32%221.25M
VESTAL POINT CAPITAL, LP4.00M750.00K+23.08%203.00M
COMMODORE CAPITAL LP3.27M00.00%166.21M
PRICE T ROWE ASSOCIATES INC /MD/2.90M2.81M+2870.84%147.37M
VANGUARD CAPITAL MANAGEMENT LLC2.57M400.84K+18.49%130.38M
CITADEL ADVISORS LLC2.07M2.03M+5631.28%105.00M
FAIRMOUNT FUNDS MANAGEMENT LLC1.86M00.00%94.17M
SIREN, L.L.C.1.77M1.03M+137.78%90.05M
BELLEVUE GROUP AG1.49M-830.87K-35.80%75.62M
GEODE CAPITAL MANAGEMENT, LLC1.41M340.78K+31.96%71.43M
FIRST LIGHT ASSET MANAGEMENT, LLC1.36M1.16M+574.08%69.06M
STATE STREET CORP1.21M122.51K+11.23%61.59M
PICTET ASSET MANAGEMENT HOLDING SA1.16M232.24K+24.98%58.96M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.08M1.08MNew54.98M
NOVO HOLDINGS A/S1.00M-280.00K-21.88%50.75M
FIRST TURN MANAGEMENT, LLC954.36K330.52K+52.98%48.43M
SAMLYN CAPITAL, LLC912.64K912.64KNew46.32M
BAKER BROS. ADVISORS LP905.19K00.00%45.94M
CANDRIAM S.C.A.905.67K311.60K+52.45%45.92M
TRI LOCUM PARTNERS LP866.72K866.72KNew43.99M
ALLIANCEBERNSTEIN L.P.896.16K124.28K+16.10%35.13M
DIMENSIONAL FUND ADVISORS LP671.41K-10.30K-1.51%34.07M

Earnings and financials

Enliven Therapeutics, Inc. (ELVN) trades at $44.48, with a market cap of $3.26B and a trailing P/E of -25.32. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Enliven Therapeutics (ELVN) Financials: Revenue & Earnings

ELVN$44.48+0.79 +1.80%

$3.26B

Market Cap

-25.32

P/E

—

Forward P/E

68

Score

Price History